MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash$1,884K Due from relatedparty$750K Prepaid expenses andother current assets$404K Other receivables$95K Property and equipment,gross$291K Total current assets$3,133K Goodwill$2,044K Right-of-use assets -operating leases, net$453K Other assets$110K Property and equipment,net$94K Less accumulateddepreciation and...$197K Total assets$5,834K Total liabilities andstockholders equity$5,834K Total liabilities$3,433K Total stockholdersequity$2,401K Accumulated deficit-$245,636K Total currentliabilities$3,113K Operating leaseliabilities, non-current$277K Other liabilities$43K Additional paid-in capital$247,997K Common stock, 0.005 parvalue, 150,000 and...$39K Preferred stock, 0.005 parvalue, 1,000 shares...$1K Accounts payable$1,125K Accrued expenses$898K Due to related party$750K Operating leaseliabilities, current$213K Other currentliabilities$83K Contingent considerationliability, current$41K Income taxes payable$3K
Balance Sheet
source: myfinsight.com

Ernexa Therapeutics Inc. (ERNAW)

Ernexa Therapeutics Inc. (ERNAW)